期刊文献+

某院质子泵抑制剂使用情况调查及干预措施 被引量:4

Investigation and intervention of proton pump inhibitors in our hospital
下载PDF
导出
摘要 目的分析某院质子泵抑制剂(PPI)使用的合理性及干预措施,为促进临床合理使用PPI提供参考。方法通过医院信息系统随机抽取2018年1~4季度使用PPI的出院患者病历各30份,对PPI的使用情况进行合理性分析,制定相应的干预措施,并评价干预后的效果。结果调查及干预后,PPI用药指征、用法用量、联合用药、溶媒及配伍等方面的合理性均有明显提高,但仍存在部分无指征预防用药情况。结论某院开展的以临床药师为主要参与人员的PPI使用情况调查和干预效果显著,但仍需继续加强PPI使用情况的监测与干预。 Objective To analyze the rationality of the use of proton pump inhibitors(PPI) in our hospital and the intervention measures, so as to provide reference for promoting the rational use of PPI in clinic. Methods 30 medical records of discharged patients using PPI were randomly selected from the hospital information system in the first four quarters of 2018. The rationality of the use of PPI was analyzed, the corresponding intervention measures were formulated, and the effect of the intervention was evaluated. Results After investigation and intervention, the rationality of PPI indications, usage and dosage, combination of drugs, solvent and compatibility were significantly improved, but there were still some cases of non-indication preventive drug use. Conclusion The results of PPI use survey and intervention carried out in our hospital with clinical pharmacists as the main participants are remarkable, but the monitoring and intervention of PPI use need to be strengthened.
作者 王香兰 孙伟 WANG Xiang-lan;SUN Wei(Department of Pharmacy,People's Hospital of Fengxian,Jiangsu Province 221700,China)
出处 《中国处方药》 2019年第12期7-9,共3页 Journal of China Prescription Drug
关键词 质子泵抑制剂 使用合理性 干预措施 Proton pump inhibitors Rationality of use Intervention measures
  • 相关文献

参考文献11

二级参考文献83

  • 1廖家智,王家.美国急性胰腺炎临床指南[J].中国消化内镜,2007,1(10):37-48. 被引量:14
  • 2Soumana C Nasser,Jeanette G Nassif,Hani I Dimassi.Clinical and cost impact of intravenous proton pump inhibitor use in non-ICU patients[J].World Journal of Gastroenterology,2010,16(8):982-986. 被引量:23
  • 3杨洁.质子泵抑制剂的药理及应用分析[J].求医问药(下半月),2013(8):269-270. 被引量:2
  • 4李兆申.重视应激性溃疡的规范化防治[J].世界华人消化杂志,2005,13(22):2637-2639. 被引量:88
  • 5Bardou M, Quenot JP, Barkun A. Stress-related mucosal disease in the critically ill patient [J]. Nat Rev Gastroenterol Hepatol, 2015, 12(2): 98-107.
  • 6Choung RS, Talley NJ. Epidemiology and clinical presentation of stress-related peptic damage and ehronic peptic ulcer [J]. Curt Mol M~d, 2008, 8(4): 253-257.
  • 7Krag M, Perner A, Wetterslev J, et al. Stress ulcer prophylaxis in the intensive care unit: is it indicated? A topical systematic re- view[J]. Acta Anaesthesiol Scand, 2013, 57(7): 835-847.
  • 8Cook DJ, Fuller HD, Guyatt GH, et al. Risk factors for gastroin- testinal bleeding in critically ill patients. Canadian Critical Care Trials Group[J]. N Engl J Med, 1994, 330(6): 377-381.
  • 9Cook D J, Griffith LE, Walter SD, et al. The attributable mortali- ty and length of intensive care unit stay of clinically important gastrointestinal bleeding in critically ill patients [J]. Crit Care, 2001, 5(6): 368-375.
  • 10Laine L, Takeuchi K, Tarnawski A. Gastric mucosal defense and cytoprotection: bench to bedside [J]. Gastroenterology, 2008,135 ( 1):41-60.

共引文献904

同被引文献30

引证文献4

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部